Tumor-suppressive activity of Hnf1β in Wilms’ tumor

References

• Breslow N, Olshan A, Beckwith JB, et al. Epidemiology of Wilms’ tumor. Med Pediatr Oncol. 1993;21(3):172–181.
   PubMedGoogle Scholar
• Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms’ tumor: developmental and clinical considerations. Am J Med Genet A. 1998;79(4):268–273.
   Web of Science ®Google Scholar
• Kalapurakal JA, Dome JS, Perlman EJ, et al. Management of Wilms‘ tumour: current practice and future goals. Lancet Oncol. 2004;5(1):37–46.
   PubMed Web of Science ®Google Scholar
• Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms‘ tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol. 2002;160(6):2181–2190.
   PubMed Web of Science ®Google Scholar
• Massa F, Garbay S, Bouvier R, et al. Hepatocyte nuclear factor 1beta controls nephron tubular development. Development. 2013;140(4):886–896.
   PubMed Web of Science ®Google Scholar
• Barbacci E, Reber M, Ott MO, et al. Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development. 1999;126(21):4795–4805.
   PubMed Web of Science ®Google Scholar
• Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrol Dial Transplant. 2004;19(11):2703–2708.
   PubMed Web of Science ®Google Scholar
• Ross-Adams H, Ball S, Lawrenson K, et al. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer. Oncotarget. 2016;7(46):74734–74746.
   PubMedGoogle Scholar
• Shen H, Fridley BL, Song H, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun. 2013;4:1628.
   PubMed Web of Science ®Google Scholar
• Chaudhary VK, Shrivastava N, Verma V, et al. Rapid restriction enzyme-free cloning of PCR products: a high-throughput method applicable for library construction. PloS One. 2014;9(10).
   Web of Science ®Google Scholar
• Garvin AJ, Re GG, Tarnowski BI, et al. The G401 cell line, utilized for studies of chromosomal changes in Wilms‘ tumor, is derived from a rhabdoid tumor of the kidney. Am J Pathol. 1993;142(2):375–380.
   PubMed Web of Science ®Google Scholar
• Wang CA, Drasin D, Pham C, et al. Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression. Cancer Res. 2014;74(24):7357–7370.
   PubMed Web of Science ®Google Scholar
• Zhu SM, Chen CM, Jiang ZY, et al. MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2. Eur Rev Med Pharmacol Sci. 2016;20(9):1712–1719.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li A, Tian Y, et al. The expression profile and clinic significance of the SIX family in non-small cell lung cancer. J Hematol Oncol. 2016;9(1):119.
   PubMedGoogle Scholar
• Senanayake U, Koller K, Pichler M, et al. The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration. Hum Pathol. 2013;44(3):336–345.
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Pierce J, de Caestecker C, et al. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms‘ tumor. J Pediatr Surg. 2012;47(6):1239–1249.
   PubMed Web of Science ®Google Scholar
• Pierce J, Murphy AJ, Panzer A, et al. SIX2 effects on Wilms’ tumor biology. Transl Oncol. 2014;7(6):800–811.
   PubMed Web of Science ®Google Scholar
• Song DJ, Yue LF, Yang HY, et al. Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma. Zhonghua yi xue za zhi. 2013;93(24):1876–1880.
   PubMedGoogle Scholar
• Wegert J, Ishaque N, Vardapour R, et al. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms’ tumors. Cancer Cell. 2015;27(2):298–311.
   PubMed Web of Science ®Google Scholar
• Anzai E, Hirata K, Shibazaki M, et al. FOXA1 induces E-cadherin expression at the protein level via suppression of Slug in epithelial breast cancer cells. Biol Pharm Bull. 2017;40(9):1483–1489.
   PubMed Web of Science ®Google Scholar
• Bhat NS, Colden M, Dar AA, et al. MicroRNA-720 regulates E-cadherin-alphaE-catenin complex and promotes renal cell carcinoma. Mol Cancer Ther. 2017.
   PubMed Web of Science ®Google Scholar
• Hussein S, Mosaad H, Rashed HE, et al. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features. Mol Biol Rep. 2017.
   PubMed Web of Science ®Google Scholar
• Liu M, Liu J, Yang B, et al. Inversed expression patterns of S100A4 and E-cadherin in cervical cancers: implication in epithelial-mesenchymal transition. Anat Rec Hoboken, N.J.: 2007. 2017.
   Google Scholar
• Liu W, Zhang X, Zhao J, et al. Inhibition of cervical cancer cell metastasis by benzothiazole through up-regulation of E-cadherin expression. Microb Pathog. 2017;111:182–186.
   PubMed Web of Science ®Google Scholar
• Ohashi W, Yamamine N, Imura J, et al. SKL2001 suppresses colon cancer spheroid growth through regulation of the E-cadherin/beta-catenin complex. Biochem Biophys Res Commun. 2017;493(3):1342–1348.
   Web of Science ®Google Scholar
• Powan P, Luanpitpong S, He X, et al. Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells. Am J Physiol Cell Physiol 2017. ajpcell.00096.2017.
   PubMed Web of Science ®Google Scholar
• Rosso M, Majem B, Devis L, et al. E-cadherin: a determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness. PloS one. 2017;12(9):e0184439.
   PubMed Web of Science ®Google Scholar
• Till JE, Yoon C, Kim BJ, et al. Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression. Cancer Res. 2017;77(19):5349–5359.
   PubMed Web of Science ®Google Scholar
• Faguer S, Mayeur N, Casemayou A, et al. Hnf-1beta transcription factor is an early hif-1alpha-independent marker of epithelial hypoxia and controls renal repair. PloS one. 2013;8(5):e63585.
   PubMed Web of Science ®Google Scholar
• Casemayou A, Fournel A, Bagattin A, et al. Hepatocyte nuclear factor-1beta controls mitochondrial respiration in renal tubular cells. J Am Soc Nephrol. 2017.
   PubMed Web of Science ®Google Scholar
• Clissold RL, Shaw-Smith C, Turnpenny P, et al. Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder. Kidney Int. 2016;90(1):203–211.
   PubMed Web of Science ®Google Scholar
• Naylor RW, Davidson AJ. Hnf1beta and nephron segmentation. Pediatr Nephrol Berlin, Germany. 2014;29(4): 659–664.
   PubMed Web of Science ®Google Scholar
• Omata M, Doke Y, Yamada C, et al. Hepatocyte nuclear factor-1beta induces redifferentiation of dedifferentiated tubular epithelial cells. PloS one. 2016;11(5):e0154912.
   PubMed Web of Science ®Google Scholar
• Boj SF, Parrizas M, Maestro MA, et al. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A. 2001;98(25):14481–14486.
   PubMed Web of Science ®Google Scholar
• Haumaitre C, Barbacci E, Jenny M, et al. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc Natl Acad Sci U S A. 2005;102(5):1490–1495.
   PubMed Web of Science ®Google Scholar
• Maestro MA, Boj SF, Luco RF, et al. Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum Mol Genet. 2003;12(24):3307–3314.
   PubMed Web of Science ®Google Scholar
• Dubois-Laforgue D, Bellanne-Chantelot C, Charles P, et al. Intellectual disability in patients with MODY due to hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Metab. 2017;43(1):89–92.
   PubMed Web of Science ®Google Scholar
• Dubois-Laforgue D, Cornu E, Saint-Martin C, et al. Diabetes, associated clinical spectrum, long-term prognosis and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1 B (HNF1B) molecular defects. Diabetes Care. 2017.
   PubMed Web of Science ®Google Scholar
• Tarnowski M, Malinowski D, Safranow K, et al. HNF1B, TSPAN8 and NOTCH2 gene polymorphisms in women with gestational diabetes. J Matern Fetal Neonatal Med. 2018;31(7):837–842.
   PubMedGoogle Scholar
• Cha JY, Kim HI, Im SS, et al. HNF1 and/or HNF3 may contribute to the tissue specific expression of glucokinase gene. Exp Mol Med. 2001;33(2):59–63.
   PubMed Web of Science ®Google Scholar
• Shi YX, Wang Y, Li X, et al. Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer. BMC Genomics. 2017;18(1):901.
   PubMedGoogle Scholar
• Shim JH, Lee HC, Han S, et al. Hepatocyte nuclear factor 1beta is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays. Liver Transpl. 2013;19(3):336–345.
   PubMed Web of Science ®Google Scholar